API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-gets-usfda-nod-for-antidepressant-medication/articleshow/109153911.cms
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216953
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216448
https://www.fiercebiotech.com/biotech/fda-nixes-eua-ambitions-eigers-covid-treatment-proposes-full-approval-pathway-instead
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211444
https://www.temad.com/en/resumption-of-fluoxetine-hydrochloride-production-after-2-years-interruption/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216232
https://www.temad.com/en/resumption-of-fluoxetine-hydrochloride-production-after-2-years-interruption/
https://www.statnews.com/2021/10/07/backed-with-500-million-a-startup-aims-to-rethink-psychiatric-drug-development/
https://www.reuters.com/article/us-health-coronavirus-science/booster-shot-improves-immune-response-of-chemotherapy-patients-post-covid-depression-helped-by-widely-used-drugs-idUSKBN2GW282
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/dash-xclusive-issues-voluntary-nationwide-recall-imperia-elita-vitaccino-coffee-due-presence-0
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202729
https://www.theguardian.com/australia-news/2020/aug/08/australia-experiencing-critical-shortage-of-antidepressants-contraceptives-and-hrt
https://www.prnewswire.com/news-releases/reneuron-announces-further-positive-data-in-retinal-clinical-trial-301085299.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213265
https://www.prnewswire.com/news-releases/reneuron-announces-ctx-cell-line-shows-further-potential-301054631.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213286
https://www.moneycontrol.com/news/business/markets/aurobindo-pharma-share-price-jumps-6-on-usfda-nod-for-antidepressant-5126111.html
https://www.prnewswire.com/news-releases/reneuron-announces-exosome-research-collaboration-301036352.html
https://www.pharmacompass.com/pdf/news/union-quimico-farmaceutica-fails-edqm-inspection-1572404101.pdf
http://www.pharmafile.com/news/530142/government-issues-first-serious-shortage-protocol-combat-lack-fluoxetine
https://www.raps.org/news-and-articles/news-articles/2019/9/product-hopping-ec-hearing-addresses-restriction
https://www.moneycontrol.com/news/business/lupin-launches-generic-antidepressant-tablets-in-us-2-4363371.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212191
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211653
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-antidepressant-tablets-in-us/articleshow/68810185.cms
https://www.reuters.com/article/us-johnson-johnson-fda/johnson-johnsons-nasal-spray-for-depression-wins-fda-panel-backing-idUSKCN1Q12G5
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211696
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211721
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211051
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211477
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-21-2018-1519194777.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209695
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209419
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208698
http://www.reuters.com/article/us-health-antidepressants-idUSKBN14V2AQ
http://www.forbes.com/sites/jasonkarlawish/2016/11/11/never-forget-the-history-of-the-future-of-treating-alzheimers-disease/#76f569ab1e0f
https://www.pharmacompass.com/pdf/news/torrents-generic-fluoxetine-hydrochloride-approved-in-us-1477391099.pdf
https://www.pharmacompass.com/pdf/news/two-lots-of-antidepressant-blisfarma-are-prohibited-1473499582.pdf
https://www.pharmacompass.com/pdf/news/par-form-generic-fluoxetine-hydrochloride-1472292854.pdf
http://www.medpagetoday.com/Psychiatry/Depression/54963
http://www.news-medical.net/news/20150902/Common-antidepressant-can-help-stroke-patients-improve-movement-and-coordination.aspx?utm_source=twitterfeed&utm_medium=twitter&utm_campaign=DTN+Pharma+News:
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/54834r-eng.php
http://www.in-pharmatechnologist.com/Processing/Italy-bans-7-APIs-from-compounding-pharmacies-after-off-label-abuse
http://www.fiercebiotech.com/story/woodford-backs-reneurons-106m-fundraise-cell-therapy-rd/2015-07-10
http://www.pharmatimes.com/Article/15-06-11/Pfizer_s_Pristiq_fails_in_paediatric_study.aspx
http://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2015/53415a-eng.php
http://www.accessdata.fda.gov/scripts/enforcement/enforce_rpt-Product-Tabs.cfm?action=select&recall_number=D-0970-2015&w=05062015&lang=eng
http://www.fiercepharmamanufacturing.com/story/attix-pharmaceuticals-recalls-hundreds-apis-us/2015-04-30
http://uk.reuters.com/article/2015/03/23/us-antidepressants-teens-side-effects-idUKKBN0MJ24C20150323